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Pattern of neurological diseases in adult 
outpatient neurology clinics in tertiary care 
hospital
Safia Awan1, Saad Shafqat1, Ayeesha Kamran Kamal1, Aziz Sonawalla1, Sarwar Siddiqui1, Fowzia Siddiqui1 
and Mohammad Wasay1,2*
Abstract 
Objectives: The burden of neurological diseases in developing countries is rising although little is known about the 
epidemiology and clinical pattern of neurological disorders. The objective of this study was to understand the burden 
of disease faced by neurologists a in tertiary care setting.
Results: A prospective observational study was conducted of all presentations to neurology clinics at Aga Khan 
University Hospital Karachi over a period of 2 years. A total of 16,371 out-patients with neurological diseases were 
seen during the study period. The mean age of the study participants were 46.2 ± 18.3 years and 8508 (52%) were 
male. Headache disorders were present in 3058 (18.6%) of patients followed by vascular diseases 2842 (17.4%), nerve 
and root lesions 2311 (14.1%) and epilepsies 2055 (12.5%). Parkinson’s disease was more prevalent in male participants 
564 (70.8%) as compared to female 257 (62.1%) (p = 0.002). Migraines and vertigo disease were more diagnosed in 
females as compared to males. Epilepsies were seen more in younger age groups. Parkinson’s disease was seen in 
50.9% of participants between the ages of 45 and 65 years, and the frequency increased with age.
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Introduction
Neurological disorders (NDs) are increasing because of 
demographic and epidemiologic changes occurring in 
both developed and developing countries. Neurological 
disorders accounted for 3.0% of global disability-adjusted 
life-years (DALYs); mainly due to epilepsy and migraines. 
While in some regions dementia was a major cause, at the 
global level NDs accounted for 11.3  million DALYs [1]. 
The overall burden of neurological disorders significantly 
increases among adults in low- and middle-income coun-
tries (LMICs) [2].
Regional differences in neurologic disorders and 
stroke related risk of death are smaller at older ages than 
at younger ages, ranging from around 40 to 60% in the 
developed countries and 70% in sub-Saharan Africa [1, 3, 
4]. The Global Burden of Disease 2010 data suggests that 
non communicable diseases (NCDs) and injuries account 
for 77% of age standardized deaths in Pakistan [5].
The burden of neurological diseases in developing 
countries is rising and it is important to know the disease 
prevalence and pattern based on geographical, social, 
cultural, religious, and ethnic factors. A population based 
study conducted in India found 3355 individuals with 
neurological disorders per 100,000 populations. The 
most frequent disorders were headache, febrile convul-
sions, epilepsy, stroke and mental retardation [6]. A study 
conducted in Saudi Arabia showed that the crude preva-
lence of neurological disorders was 131/1000 population. 
Headache, epilepsy, febrile convulsions and mental retar-
dation were common as compared to stroke, dementias 
and Parkinson’s disease [7].
The available information on the pattern and frequency 
of major neurological disorders in Pakistan is limited 
to hospital-based populations who may not be totally 
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representative of the community. The incidence or preva-
lence of neurological diseases in Pakistan is not known 
[8]. However the Global Burden of Disease 2010 data 
suggests that more than half of disability due to neuro-
logical diseases is related to stroke followed by demen-
tias, migraine, epilepsy and tetanus [9].
The estimated prevalence of people with dementia 
in Pakistan is around 200,000. The estimated volume of 
visits to neurology clinics in Pakistan is close to 200,000 
visits per year. The demographics and diagnosis of these 
patients may vary from area to area. A data base of 
demographics and diagnosis of outpatients seen at neu-
rology clinics at a tertiary care hospital not only identifies 
the frequency of different neurological diseases but also 
includes patient details such as gender and age groups. 
Findings from this database may open up avenues for fur-
ther research, particularly in the development of commu-
nity based studies and interventions/clinical trials to help 
improve the health of the population.
Aims and objectives
The overall aim of the study was to generate knowledge 
about neurological disorders NDs in patients attending 
neurologic clinics in a low-income setting and to contrib-
ute the neglected public health field in Pakistan.
The main objective of the study was to estimate the fre-
quency of the main NDs in outpatient neurological clin-
ics at a tertiary care hospital in Karachi
Main text
Methods
Study design and setting
The records of all out-patients (18 years and above) seen 
in neurological clinics were collected at Aga Khan Uni-
versity (AKU) hospital from January 2014 to December 
2015. A retrospective observational study was conducted 
of all presentations to neurology clinics over a period of 
2  years. The study was approved by the Ethical Review 
Committee (ERC) of the Aga Khan University.
Data collection
The WHO protocol for the detection of major neuro-
logical disorders was used as the basis for the question-
naire. The questionnaire was tested and modified to suit 
the needs of this study. The questionnaire was designed 
to collect data on demographics including age, sex, place 
and type of residence (rural/urban), referral and patient’s 
evaluation status (new versus follow-up patient). A diag-
nosis as a referenced neurology case was determined by 
neurologist after conducting a physical examination of 
the patient. The main types of NDs along with sub-group 
were offered in the questionnaire to record the exact neu-
rological disorder [10].
Uniform and standard criteria was used by neurologists 
for the diagnosis of cases. For each disorder, WHO clas-
sifications and definitions were used to assess the neuro-
logical disorder as follows. (1) Vascular diseases, (2) CNS 
infections, (3) demyelinating diseases, (4) movement dis-
orders, (5) cerebellar ataxias and hereditary spastic para-
plegias, (6) CNS neoplasms, (7) dementias, (8) epilepsies, 
(9) headache disorders, (10) nerve and root lesions, (11) 
myopathies/muscle disorders, (12) spinal disorders, (13) 
acquired metabolic and toxic disorders, (14) psychiatric 
disorders, (15) developmental disorders, and (16) neuro-
metabolic/nutritional disorders of the nervous system.
The diagnoses were made clinically with laboratory 
and radiological confirmation. Radiological tests used 
included CT-scans (brain and spine), spine X-rays, and 
MRI. Electrophysiological tests included electroencepha-
lography (EEG), electroneuromyography (ENMG), and 
electrocardiography (ECG).
Statistical analysis
Descriptive analysis for demographic variables was per-
formed; results were reported as numbers with percent-
ages for quantitative variables, and mean  ±  standard 
deviation or median with ranges for all qualitative vari-
ables. Comparison between different age groups and 
gender with neurological diseases were performed using 
Pearson Chi square test. p < 0.05 was considered as sta-
tistically significant; all p values were two sided. SPSS 
19.0 (SPSS Inc., Chicago: IL, USA) was used for data 
entry and analysis.
Results
A total of 16,371 out-patients with neurological diseases 
were seen during the study period. The mean age of the 
study participants was 46.2 ± 18.3 years with median of 
46  years. Patients over 40  years made up 8389 (51.2%) 
of the participants. A total of 8508 (52%) were male and 
7867 (48.1%) were female.
The frequency of various neurological disorder groups 
is shown in Table 1. Headache disorders were present in 
18.6% of patients followed by vascular diseases 17.4%, 
nerve and root lesions 14.1%, epilepsies 12.5%, psychi-
atric disorders 11.7% and neurometabolic/nutritional 
disorders 11.3%. Among the vascular group stroke was 
presented in 2792 (98.2%) of patients. The most common 
sub type was ischaemic stroke 2277 (81.6%) followed by 
haemorrhagic stroke 294 (10.5%). Migraine 1698 (55.5%) 
was the most common presentation amongst the head-
ache disorder group. The most common presentation 
among the sleep disorders group was obstructive sleep 
apnoea 105/195 (53.8%) followed by restless leg syn-
drome 87/195 (44.6%). Among the CNS infections group, 
tuberculous meningitis 162 (65.3%), viral meningitis 
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44 (17.7%) and bacterial meningitis 32 (12.9%) were the 
most common presentations. The dementia group is 
mainly constituted of two types of diseases; Alzheimer’s 
211 (45.8%) followed by dementia 207 (45%). Among 
Table 1 Diagnosis profile of  the study population 
n = 16,371
Diagnosis n %
Vascular disease 2842 17.4
Stroke 2792/2842 98.2
Types (n = 2729)
 Ischaemic stroke 2277 81.6
 Transient stroke 170 6.1
 Haemorrhagic stroke 294 10.5
 Ischemia and hemorrhagic 19 0.7
 Ischemia and transient 30 1.1
 Transient and hemorrhage 2 0.1
Cerebellar ataxias and hereditary spastic paraplegias 311 1.9
Motor neuron diseases 60 19.2
Sleep disorders 195
Restless leg syndrome 87 44.6
Obstructive sleep apnoea 105 53.8
Headache disorders 3058 18.6
Type of headache (n = 1370)
 Headache disorder 651 21.2
 Tension type headache 574 18.7
 Cluster headache 29 0.68
 Chronic headache 28 2.04
 Headache due to psychiatric disorder 26 1.89
 Headache attributed to head and/or neck trauma 11 0.35
Migraine 1698/3058 55.5
Acquire metabolic and toxic disorders 13 0.07
CNS infection 314 0.01
Meningitis (n = 248)
Bacterial meningitis 32 12.9
Tuberculous meningitis/tuberculoma 162 65.3
Fungal meningitis 6 2.4
Viral meningitis 44 17.7
Symptomatic meningitis 4 1.6
CNS neoplasm 151 0.92
Meningioma 27 17.8
Oligodendroglioma 23 15.2
Pituitary adenoma 20 13.2
Glioma 15 9.9
Nerve and root lesion 2311 14.1
Cervical radiculopathy 369 15.9
Carpal tunnel syndrome 153 6.6
Diabetic polyneuropathy 129 5.5
Guillain–Barre syndrome(AIDP) 94 4.0
Psychiatric disorders 1916 11.7
Depression 1486 77.5
Anxiety 188 9.8
Conversion disorders 86 4.4
Demyelinating diseases 181 1.10
Multiple sclerosis 121/181 6.6
Dementias 460 2.8
Alzheimer’s diseases 211 45.8
Table 1 continued
Diagnosis n %
Dementia frontal/vascular 207 45
Myopathies/muscle disorders 1734 10.5
Musculoskeletal pain 1017 58.6
Myasthenia gravis 190 10.9
Fibromyalgia 193 11.1
Myopathies/muscle disorders 49 2.8
Neck strain 39 2.2
Polymyositis 33 1.9
Development disorders 81 0.49
Mental retardation 19 23.4
Movement disorders 1211 7.3
Parkinson’s diseases 821 67.7
Dystonias 141 11.6
Essential tremor 89 7.3
Epilepsies 2055 12.5
Epilepsy 326 23.3
Partial epilepsy with or without generalization 629 44.9
Generalised epilepsy 373 26.6
Juvenile myoconic epilepsy 55 3.9
Seizures 591 28.7
Febrile seizures 7 1.2
Seizures vs. Pseudoseizures 13 2.2
Fits 91 15.4
Complex partial seizures 3 0.5
Seizures 439 74.3
GTC (general tonic chronic seizures) 16 2.7
Pseudoseizures 12 2.7
 Non-epileptic seizures 2 2.0
 Post traumatic seizures 3 0.5
 Systematic seizures 1 0.2
 Neonate seizure 1 0.2
 Focal seizures 2 0.3
 Syncopy vs. seizures 1 0.2
Spinal disorders 124 0.75
Myelitis 62 50
Myelopathy 62 50
Others
Bell palsy 161 0.98
Vertigo 510 3.11
Encephalopathy 33 0.20
Neurometabolic/nutritional 174 1.06
Vitamin D deficiency osteomalacic 72 41.3
B12 deficiency 80 45.9
Wilson disease 22 12.6
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movement disorders, Parkinson’s disease 821 (67.7%) was 
the most common presentation, followed by dystonia 141 
(11.6%). Partial epilepsy with or without generalization 
629 (44.9%) was the most common type of epilepsies fol-
lowed by generalized epilepsy 373 (26.6%) and epilepsy 
326 (23.3%). Musculoskeletal pain 1017 (58.6%) was the 
most common presentation of myopathies. Vertigo was 
seen in 510 (3.11%) patients followed by Bell’s palsy 161 
(0.98%). The frequency of the top neurological diseases 
seen in out-patient clinics are presented in Fig.  1. The 
frequencies of neurological diseases in patients above 
the age of 45 years are presented in Additional file 1. The 
prevalence of stroke was similar in both genders. Parkin-
son’s disease was more prevalent in males 564 (70.8%) 
than females 257 (62.1%); (p  =  0.002). Epilepsies were 
seen more in males 737 (71.3%) as compared to females 
665 (65.1%); (p = 0.003). Migraines 1231 (60.7%) versus 
467 (45.4%) and vertigo disease 260 (61.6%) versus 249 
(49.7%) were more common in females as compared to 
males; Table 2. Of the Parkinson’s disease patients 50.9% 
were between the ages of 45 and 65 years. A comparison 
of different disease and age groups is shown in Additional 
file 2.  
Discussion
The study was designed to investigate the frequency of 
NDs in Pakistan. NDs commonly cause public health 
challenges, creating burdens and disability.
In our study, the age group between 46 and 65  years 
represented 34% of all out-patient visits. A study from 
Dhaka, Bangladesh reported 59.7% of admissions in 
neurology were after the age of 40  years [11]. A study 
from Nigeria reported 40.8% were aged between 51 and 
60 years [12]. The mean age of the study participants was 
46 years which was similar to the mean age reported in 
other studies done in Pakistan [13], Bangladesh [11] and 
African countries [14–16]. Most patients were self-refer-
rals and the leading diagnosis in our study were head-
ache, stroke, epilepsies, depression, musculoskeletal pain, 
Parkinson’s, vertigo, cervical radiculopathy, dementia and 
meningitis. The leading cause of headache disorders is 
similar to the study by Alam et al. conducted in Peshawar, 
Pakistan [13], Anand et al. from India [17], and Callixte 
et al. from sub-Saharan Africa [16, 18].
The most common cause of out-patient visits was 
stroke (98.2%), which is similar to previous studies [11, 
12, 14, 16, 19]. According to WHO estimates in 2001, 
Fig. 1 The ten leading diseases in the out-patients neurology clinics
Table 2 Distribution of diagnosis among male and females
Male, n (%) Female, n (%) p value
Stroke, n = 2792 1795 (98.6) 997 (97.6) 0.052
Meningitis, n = 248 127 (78.4) 121 (80.1) 0.78
Parkinson’s disease, n = 821 564 (70.8) 257 (62.1) 0.002
Epilepsy, n = 1402 737 (71.3) 665 (65.1) 0.003
Musculoskeletal pain, n = 1017 471 (59.1) 546 (58.3) 0.73
Migraine, n = 1698 467 (45.4) 1231 (60.7) < 0.001
Vertigo, n = 510 249 (49.7) 260 (61.6) < 0.001
Alzheimer’s, n = 211 106 (43.8) 105 (48.2) 0.35
Dementia, n = 207 104 (43) 103 (47.2) 0.39
Obstructive sleep apnoea, 
n = 105
60 (33.3) 45 (34.4) 0.90
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86% of deaths related to stroke worldwide occurred in 
developing countries [20].
A population-based study [21] from Pakistan showed 
a much higher prevalence of stroke 19,000 per 100,000 
population (19·1%) in comparison with worldwide lit-
erature. A study from India estimates the prevalence of 
stroke ranges from 44 to 843 per 100,000 population [22]. 
Further studies are needed to determine the prevalence 
of stroke subtypes between Pakistani and Western pop-
ulations [23]. Furthermore, meningitis was the second 
leading cause of out-patient clinic visit in our study. A 
prior study reported headache as the most common pres-
entation, followed by cerebrovascular accidents and epi-
lepsy [13]. A study from Bangladesh reported that stroke 
and seizures were the most seen diagnosis [11]. Other 
than meningitis, epilepsy was the most common neu-
rological disorder and the highest prevalence is seen in 
people under 30 years of age [24]. Approximately 50 mil-
lion people worldwide have epilepsy, making it one of the 
most common neurological disorders [25].
Neurodegenerative diseases are frequent in older 
populations. Meta-analysis of worldwide data showed 
the prevalence of Parkinson’s disease rising with age. 
An estimated 7 to 10 million people are living with Par-
kinson’s disease [26]. Prevalence differed by geographic 
location [27], however, dementia was seen both in young 
and older age groups [28]. The prevalence of dementia in 
South Asia is estimated to be 1.9% [29]. Alzheimer’s dis-
ease is responsible for 45.8% of admissions in our neuro-
logical setting.
Mental illnesses in Pakistan depicts a gloomy picture 
with a 6% prevalence of depression, 1.5% schizophrenia, 
1–2% epilepsy and 1% of Alzheimer’s disease [30]. Due to 
a lack of research, it is difficult to get an accurate number 
of people suffering from these diseases.
Pakistan’s estimated population is over 194.9  million, 
making it one of the world’s most-populous countries. 
At least 10% of the population of Pakistan suffers from 
neurological diseases. More than 70% of medical col-
leges and almost 75% of government hospitals are with-
out neurologists. Pakistan produces 10–20 neurologists 
annually out of which 50% leave the country. The present 
study lays a foundation of data regarding ND burden in 
this region to build a registry of data and address the gap 
in existing information about this neglected area of dis-
ease epidemiology.
Limitation
We had some limitations in this study. First, this study 
is a hospital-based design and patients were seen only 
once by the neurologist so follow up data was unavail-
able. Second, this study was conducted in an urban cen-
tre so the data is not necessarily representative of the 
whole country. Further studies involving large cohorts 
are required to validate these findings in both urban and 
rural populations.
Abbreviations
NDs: neurological disorders; DALYs: disability-adjusted life-years; ECG: 
electrocardiography.
Authors’ contributions
MW developed the idea. SA wrote the manuscript and performed the 
statistical analysis. SS1 drafting the manuscript. AKK and SS2: review of final 
manuscript. AzS: development and testing of the instrument. FS: develop-
ment of the instrument. All authors contributed to check the final diagnosis of 
each patient, the literature review, and the review of the final draft. All authors 
read and approved the final manuscript.
Author details
1 Section of Neurology, Department of Medicine, Aga Khan University Hospital 
Karachi, Karachi, Pakistan. 2 Department of Neurology, Aga Khan University, 
Stadium Road, Karachi 74800, Pakistan. 
Acknowledgements
We acknowledge our team of data collectors for their hard work and 
dedication.
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
The datasets analysed during the current study are provided within the 
manuscript. The SPSS data file used during the current study are available in 
Additional file 3.
Consent to publish
Not applicable.
Ethics approval and consent to participate
The study was approved by the Ethical Review Committee (ERC) of the Aga 
Khan University.
All data used in this study is publicly available. No effort is made by the 
authors to determine the identity of any cases, or to use the information for 
any purpose other than for statistical reporting and analysis.
Funding
The authors were partially supported by Departmental Research funds.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
Received: 1 June 2017   Accepted: 24 October 2017
Additional files
Additional file 1. The ten leading diseases in the out-patient neurology 
clinics. Leading diseases among patients above the age of 45 years.
Additional file 2. Age wise distribution of diagnosis. Description of data: 
age wise distribution of leading diagnosis.
Additional file 3. Demographic and clinical characteristics.
Page 6 of 6Awan et al. BMC Res Notes  (2017) 10:545 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
References
 1. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, 
Ezzati M, Shibuya K, Salomon JA, Abdalla S. Disability-adjusted life 
years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a 
systematic analysis for the Global Burden of Disease Study 2010. Lancet. 
2012;380(9859):2197–223.
 2. Birbeck GL, Meyer A-C, Ogunniyi A. Nervous system disorders across the 
life course in resource-limited settings. Nature. 2015;527(7578):S167–71.
 3. Mathers CD, Lopez AD, Murray CJL. The burden of disease and mortality 
by condition: data, methods and results for 2001. In: Lopez AD, Mathers 
CD, Ezzati M, Jamison DT, Murray CJL, editors. Global Burden of Disease 
and Risk Factors. Washington (DC): World Bank; 2006.
 4. Chin JH, Vora N. The global burden of neurologic diseases. Neurology. 
2014;83(4):349–51.
 5. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham 
J, Adair T, Aggarwal R, Ahn SY. Global and regional mortality from 
235 causes of death for 20 age groups in 1990 and 2010: a system-
atic analysis for the Global Burden of Disease Study 2010. Lancet. 
2013;380(9859):2095–128.
 6. Gourie-Devi M, Gururaj G, Satishchandra P, Subbakrishna DK. Prevalence 
of neurological disorders in Bangalore, India: a community-based study 
with a comparison between urban and rural areas. Neuroepidemiology. 
2004;23(6):261–8.
 7. Al Rajeh S, Bademosi O, Ismail H, Awada A, Dawodu A, Al-Freihi H, Assu-
haimi S, Borollosi M, Al-Shammasi S. A community survey of neurologi-
cal disorders in Saudi Arabia: the Thugbah study. Neuroepidemiology. 
1993;12(3):164–78.
 8. Wasay M. Neurological care in Pakistan: actions are needed. J Pak Med 
Assoc. 2003;53(12):576.
 9. World Health Organization. Neurological disorders: public health chal-
lenges. Geneva: World Health Organization, 2006.
 10. World Health Organization. International statistical classification of 
diseases and related health problems. 2009.
 11. Chowdhury RN, Hasan ATMH, Rahman YU, Khan SI, Hussain AR, Ahsan S. 
Pattern of neurological disease seen among patients admitted in tertiary 
care hospital. BMC Res Notes. 2014;7(1):1.
 12. Owolabi LF, Shehu MY, Shehu MN, Fadare J. Pattern of neurological 
admissions in the tropics: experience at Kano, Northwestern Nigeria. Ann 
Indian Acad Neurol. 2010;13(3):167.
 13. M Alam S, Khan H, Wahid K. Spectrum of neurological disorders present-
ing at a neurology clinic in tertiary care hospital in Peshawar, Pakistan. Pak 
J Neurol Sci. 2015;10(4):23–6.
 14. Ojini FI, Danesi MA. The pattern of neurological admissions at the Lagos 
University Teaching Hospital. Niger J Clin Pract. 2003;6(1):38–41.
 15. Eze CO, Kalu UA. Pattern of neurological admissions in the tropics: experi-
ence at Abakaliki South-Eastern Nigeria. Niger J Med. 2014;23(4):302–5.
 16. Tegueu CK, Nguefack S, Doumbe J, Fogang YF, Mbonda PC, Mbonda 
E. The spectrum of neurological disorders presenting at a neurology 
clinic in Yaoundé, Cameroon. Pan Afr Med J. 2013;14:148. doi:10.11604/
pamj.2013.14.148.2330.
 17. Anand KS, Singh MMC, Chandra SMM. Pattern of neurological disorders 
above the middle aged population in JIPMER, Pondicherry. Neurol India. 
1993;41(3):157.
 18. Callixte K-T, Clet TB, Jacques D, Faustin Y, FranÃ§ois DJ, Maturin T-T. The 
pattern of neurological diseases in elderly people in outpatient consulta-
tions in sub-Saharan Africa. BMC Res Notes. 2015;8(1):1.
 19. Gajurel BP, Parajuli P, Nepali R, Oli KK. Spectrum of neurological disorders 
admitted in Tribhuvan University Teaching Hospital Maharajgunj. J Inst 
Med. 2012;34:50–3.
 20. Khealani BA, Hameed B, Mapari UU. Stroke in Pakistan. J Pak Med Assoc. 
2008;58(7):400.
 21. Kamal AK, Itrat A, Murtaza M, Khan M, Rasheed A, Ali A, Akber A, Akber Z, 
Iqbal N, Shoukat S. The burden of stroke and transient ischemic attack in 
Pakistan: a community-based prevalence study. BMC Neurol. 2009;9(1):1.
 22. Prasad K, Vibha D. Cerebrovascular disease in South Asia—Part I: a burn-
ing problem. JRSM cardiovasc Dis. 2012;1(7):20.
 23. Wasay M, Khatri IA, Kaul S. Stroke in South Asian countries. Nature Rev 
Neurol. 2014;10(3):135.
 24. Khatri IA, Iannaccone ST, Ilyas MS, Abdullah M, Saleem S. Epidemiology of 
epilepsy in Pakistan: review of literature. JPMA. 2003;53(12):594–7.
 25. World Health Organization. Epilepsy—fact sheet. Geneva: World Health 
Organization; 2016.
 26. (PDF) PsDF. Statistics on Parkinson’s. 2016.
 27. Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of Par-
kinson’s disease: a systematic review and metaâ analysis. Mov Disord. 
2014;29(13):1583–9.
 28. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global 
prevalence of dementia: a systematic review and metaanalysis. Alzhei-
mer’s Dement. 2013;9(1):63–75.
 29. Ahmad A, Owais K, Siddiqui M, Mamun K, Rao F, Yousufzai AW. Dementia 
in Pakistan: national guidelines for clinicians. Pak J Neurol Sci (PJNS). 
2013;8(3):17–27.
 30. Gadit AAM, Vahidy A. Mental health morbidity pattern in Pakistan. J Coll 
Physicians Surg Pak. 1999;9:362–5.
